Linscomb & Williams, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Linscomb & Williams, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $899,322 - $1.17 Million	-1,823 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $377,530 - $555,244	-1,123 Reduced 38.12%	1,823 $890,000
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $807,586 - $1.11 Million	2,946 New	2,946 $1.11 Million

1,531

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

Stay updated on Linscomb & Williams, Inc. with notifications on news.